BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1353229)

  • 21. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
    Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
    Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endometrial cancer during tamoxifen treatment. Cancer Research Campaign Breast Cancer Trials Group.
    Baum M; Odling-Smee W; Houghton J; Riley D; Taylor H
    Lancet; 1994 May; 343(8908):1291. PubMed ID: 7910295
    [No Abstract]   [Full Text] [Related]  

  • 23. [Development of endometrial cancer during tamoxifen therapy].
    Rasmussen KL; Nielsen KM
    Ugeskr Laeger; 1991 Sep; 153(38):2638. PubMed ID: 1949276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.
    Clarke RB; Laidlaw IJ; Jones LJ; Howell A; Anderson E
    Br J Cancer; 1993 Mar; 67(3):606-11. PubMed ID: 8439511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tamoxifen therapy--long-term results and complications.
    Moore MP; Kinne DW
    Adv Surg; 1996; 29():263-9. PubMed ID: 8720007
    [No Abstract]   [Full Text] [Related]  

  • 26. ACOG committee opinion. Tamoxifen and endometrial cancer. Number 169, February 1996. Committee on Gynecologic Practice. American College of Obstetricians and Gynecologists.
    Int J Gynaecol Obstet; 1996 May; 53(2):197-9. PubMed ID: 8735304
    [No Abstract]   [Full Text] [Related]  

  • 27. Tamoxifen and endometrial cancer.
    Segna RA; Dottino PR; Deligdisch L; Cohen CJ
    Mt Sinai J Med; 1992 Oct; 59(5):416-8. PubMed ID: 1435840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen and risk of endometrial cancer.
    Marsh F; Mayfield M
    Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197382
    [No Abstract]   [Full Text] [Related]  

  • 29. Tamoxifen and risk of endometrial cancer.
    Kairies P
    Lancet; 2001 Jan; 357(9249):68. PubMed ID: 11197381
    [No Abstract]   [Full Text] [Related]  

  • 30. Tamoxifen and risk of endometrial cancer.
    Lasset C; Bonadona V; Mignotte H; Brémond A
    Lancet; 2001 Jan; 357(9249):66-7. PubMed ID: 11197379
    [No Abstract]   [Full Text] [Related]  

  • 31. Tamoxifen and risk of endometrial cancer.
    Atkins CD
    Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197378
    [No Abstract]   [Full Text] [Related]  

  • 32. Tamoxifen and risk of endometrial cancer.
    Tempfer C; Kubista E
    Lancet; 2001 Jan; 357(9249):65; author reply 67. PubMed ID: 11197377
    [No Abstract]   [Full Text] [Related]  

  • 33. Tamoxifen and risk of endometrial cancer.
    Narod SA; Pal T; Graham T; Mitchell M; Fyles A
    Lancet; 2001 Jan; 357(9249):65-6; author reply 67. PubMed ID: 11197376
    [No Abstract]   [Full Text] [Related]  

  • 34. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of hormonal receptors (alpha-estrogen, beta-estrogen, progesteron), Ki-67 and P53 in endometrium of tamoxifen treated breast cancer patients].
    Negoiţă M; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):834-8. PubMed ID: 22046795
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
    Sinawat S; Chiyabutra T; Kleabkaew P
    J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tamoxifen therapy for breast cancer and endometrial cancer risk.
    Bernstein L; Deapen D; Cerhan JR; Schwartz SM; Liff J; McGann-Maloney E; Perlman JA; Ford L
    J Natl Cancer Inst; 1999 Oct; 91(19):1654-62. PubMed ID: 10511593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Steroid receptor enhancement by natural interferon-beta in advanced breast cancer.
    Sica G; Iacopino F; Lama G; Amadori D; Baroni M; Lo Sardo F; Malacarne P; Marchetti P; Pellegrini A; Zaniboni A
    Eur J Cancer; 1993; 29A(3):329-33. PubMed ID: 8398327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of tamoxifen therapy on endometrium in breast cancer patients].
    Jiang SS; Tao RF
    Zhonghua Fu Chan Ke Za Zhi; 1995 Jan; 30(1):53-5. PubMed ID: 7750409
    [No Abstract]   [Full Text] [Related]  

  • 40. [Postmenopausal hemorrhage and endometrial cancer in tamoxifen therapy].
    Krause A; Gerber B
    Zentralbl Gynakol; 1994; 116(1):44-7. PubMed ID: 8147180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.